Author:
Wang He-ran,Gong Meng-chun,Sun Jing-Yuan,Sun Jian,Guo Yi,Liu Li,Zhu Hong
Abstract
Abstract
Background
Novel coronavirus pneumonia has been the most serious worldwide public health emergency since being identified in December 2019. The rapid spread of the pandemic and the strong human to human infection rate of COVID-19 poses a great prevention challenge. There has been an explosion in the number of confirmed cases in several cities near Wuhan, including the highest in Honghu, Jinzhou. Owing to the limited admission capacity and medical resources, increasing numbers of suspected cases of COVID-19 infection were difficult to confirm or treat.
Case presentation
Following the arrival of the Guangdong medical aid team on 11 February, 2020, COVID-19 care in Honghu saw changes after a series of solutions were implemented based on the ‘Four-Early’ and ‘Four-centralization’ management measures. The ‘Four-Early’ measures are: early detection, early reporting, early quarantine, and early treatment for meeting an urgent need like the COVID-19 pandemic. ‘Four-centralization’ refers to the way in which recruited medical teams can make full use of medical resources to give patients the best treatment. These solutions successfully increased the recovery rate and reduced mortality among patients with COVID-19 in Honghu.
Conclusions
This management strategy is called the ‘Honghu Model’ which can be generalized to enable the prevention and management of COVID-19 worldwide.
Funder
Innovative Research Group Project of the National Natural Science Foundation of China
Guangdong Province Higher Vocational Colleges and Schools Pearl River Scholar Funded Scheme
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Infectious Diseases,Microbiology (medical),Public Health, Environmental and Occupational Health
Reference7 articles.
1. Velavan TP, Meyer CG. The COVID-19 pandemic. Trop Med Int Health. 2020;25(3):278–80.
2. Chen W, Wang Q, Li YQ, Yu HL, Xia YY, Zhang ML, Qin Y, Zhang T, Peng ZB, Zhang RC, et al. Early containment strategies and core measures for prevention and control of novel coronavirus pneumonia in China. Zhonghua Yu Fang Yi Xue Za Zhi. 2020;54(3):1–6.
3. Flora GD, Nayak MK. A brief review of cardiovascular diseases, associated risk factors and current treatment regimes. Curr Pharm Des. 2019;25(38):4063–84.
4. Guo L, Wei D, Zhang X, Wu Y, Li Q, Zhou M, Qu J. Clinical features predicting mortality risk in patients with viral pneumonia: The MuLBSTA Score. FRONT Microbiol. 2019;10:2752.
5. Wang H, Wang S, Yu K. COVID-19 infection pandemic: the medical management strategies in Heilongjiang Province, China. Crit Care. 2020;24(1):107.